Differential expression of translation-associated genes in benign and malignant human breast tumours. by Adams, S. M. et al.
Br. J. Cancer (1992), 65, 65 71
© Macmillan Press
Differential expression of translation-associated genes in benign and
malignant human breast tumours
S.M. Adams', M.G.F. Sharpl'*, R.A. Walker2, W.J. Brammarl & J.M. Varley"2
1University/ICI Joint Laboratory and 2Department ofPathology, University ofLeicester, University Road,
Leicester LEJ 7RH, UK.
Summary The human gene sequences encoding the translation-associated functions of a-subunit of elonga-
tion factor 1 (EF-la) and the ubiquitin carboxyl extension protein (HUBCEP80) have been isolated by
differential cDNA screening, and found to have significantly higher levels of expression in fibroadenomas
(benign) compared with carcinomas (malignant) of the breast. These data parallel our previous findings that
the acidic ribosomal phosphoprotein P2 also has higher expression levels in the benign breast tumours (Sharp
et al., 1990). In situ hybridisation has shown these genes to be expressed predominantly in the epithelium of
breast tumours.
Metastasis is a complex process which involves both the
dissemination of tumour cells from the site of the primary
tumour and their subsequent establishment at a distant site.
In breast cancer metastasis is the primary cause of death, but
there is great diversity in the clinical course of the disease
and metastases may not become evident for up to 25 years
(Brinkley & Haybittle, 1975; Blamey et al., 1979). Assays to
identify which tumours have greater metastatic potential
would be of benefit in the design of therapeutic regimes, since
absence of metastases at time of presentation is a good
prognostic indicator (Fisher et al., 1984).
Tumour progression may involve genetic changes or altera-
tions which affect the expression of specific genes. Metastasis
of certain tumours has been related to secreted proteinases
(Mullins & Rohrlich, 1983; Zucker, 1988; Matrisian & Bow-
den, 1990) and cell surface antigens (Feldman & Eisenbach,
1988). Changes in homotypic cell adhesion (Updyke & Nich-
olson, 1986), intercellular communications (Hamada et al.,
1988; Nicholson et al., 1988) and growth autonomy (Chad-
wick & Lagarde, 1988) also correlate with metastatic capa-
city. However, no single marker has been identified which
distinguishes between metastasising and non-metastasising
cells of a specific organ, let alone between tumours arising in
different sites.
Differential screening of cDNA libraries has been used
successfully by several groups to identify genes which have
altered expression patterns between malignant and non-
malignant tumours. One example of such a gene is NM23,
first isolated by differential screening of K-1735 murine mela-
noma cell lines with varying metastatic potentials, where
higher expression of NM23 was shown to be associated with
low metastatic potential (Steeg et al., 1988). It was subse-
quently found that NM23 gene expression in 71 human
primary breast carcinomas was inversely correlated with
histopathological indicators of metastatic potential, including
number of involved lymph nodes and tumour grade, and
positively associated with longer disease-free interval and
overall survival (Hennessy et al., 1991). The NM23 protein
has high (77%) homology to a Dictyostelium nucleoside
diphosphate kinase Gipl7 (Wallet et al., 1990). Similarly, two
novel genes WDNM1 and WDNM2 have been isolated from
the rat mammary adenocarcinoma cell line DMBA-8 by
comparision of gene expression in clones with differing meta-
static potential (Dear et al., 1988, 1989). These both showed
higher expression in cell lines with lower metastatic potential.
WDNM2 is reported to be the gene encoding NAD(P)H:
menadione oxidoreductase (Dear, 1990).
In order to identify genes involved in the early stages of
metastasis we have carried out differential screening of a
cDNA library, constructed from mRNA from a carcinoma of
the breast, using radio-labelled probes derived from both
malignant (carcinoma) and non-malignant (fibroadenoma)
breast tumours. We have isolated sequences with higher ex-
pression in the benign tissue (fibroadenoma) compared with
the malignant tissue (carcinoma), and shown them to specify
elongation factor-la (EF-1a) and human ubiquitin carboxyl
extension protein (HUBCEP80); both proteins involved in
translation. We have previously reported that the gene for
another translation-associated protein, acidic ribosomal
phosphoprotein P2, isolated as encoding a metastasis-related
protein by Elvin et al. (1988), has higher levels of RNA
expression in benign tumours compared with malignant
tumours (Sharp et al., 1990).
Materials and methods
Tissues
Human breast tumour samples from 17 carcinomas and 17
fibroadenomas were frozen immediately in liquid nitrogen
after surgical resection, and stored subsequently at -70°C.
Parallel slices of tissue from all cases were fixed in 4%
formaldehyde in saline and processed through paraffin wax
for routine histopathology and for in situ hybridisation. Car-
cinomas were classified according to WHO criteria, and
histological differentiation assessed as described in Varley et
al. (1987).
Materials
G-tailed plasmid vector pUC9 was purchased from Phar-
macia. Radioisotopes were from Amersham. All enzymes
were from Bethesda Research Laboratories or Sigma, except
for avian myeloblastosis virus reverse transcriptase (Life
Sciences), T3 RNA polymerase (Gibco-BRL), T7 RNA poly-
merase and proteinase K (Boehringer-Mannheim), placental
ribonuclease inhibitor and DNase I (Amersham). Nylon
membranes were purchased from Amersham. RNA slot blots
were made using the Hybri-Slotm manifold (Gibco-BRL).
Oligo(dT) was from Pharmacia. Photographic emulsion
(Ilford K5), developer (Kodak D19) and fixer (Kodak Unifix)
were used to process tissue sections subjected to in situ
hybridisation analysis.
RNA preparation
RNA samples were prepared as previously described (Whit-
taker et al., 1986; Varley et al., 1987). All solutions contain-
ing RNA were stored at - 70°C. RNA samples were analysed
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by spectrophotometry and agarose gel electrophoresis tbr
purity and yield. The latter demonstrated that the ribosomal
RNA bands were intact and that there was no contamination
with cellular DNA (data not shown).
Preparation ofthe cDNA library
Preparation of the cDNA library from a poorly differentiated
infiltrating ductal carcinoma with no evidence oflymph node
metastasis (T2NoMo: see Hermanek & Sobin, 1987) was as
described in Sharp et al. (1990).
Probe preparation
Radio-labelled cDNA probes were made from 30-40 ng of
poly(A+) RNA or from 4fg of total RNA. RNA was
annealed to 1 tLg of oligo(dT) by heating to 72°C for 1 min,
and 42°C for 2 min. Reverse transcription was carried out
using 19 units of AMV reverse transcriptase in 50 mM Tris-
HCl, pH 8.3; 10 mM MgCI2; 0.1 mg ml-' BSA; 10 mM DTT;
40 I4M dATP, dGTP and dTTP; 50 mM KCl (all made up in
DEPC-treated water), with 66 pmol of dCTP, and 20 pmol of
[_-32P]-dCTP at 42°C for 35 min. The RNA was hydrolysed
by the addition of NaOH to 250 mM and incubation at 70°C
for 12 min, then neutralised with an equal volume of 1 M
Tris-HCI, pH 6.8. On average, 1.5-2.0 x I05 c.p.m. ml1
were added to each hybridisation in the screening experi-
ments, which included no more than eight membranes (9 cm
in diameter) in 20 ml of solution. For slot blot analysis, the
conditions used for cDNA synthesis were optimised for full-
length products (Retzel et al., 1980), using trace amounts of
[_-32P]-dCTP to follow the reaction. The recovered cDNA
was then labelled by random priming (Feinberg & Vogel-
stein, 1983), to a specific activity of 106 c.p.m. Lg' .
Double-stranded DNA probes were labelled by the ran-
dom priming method of Feinberg and Vogelstein (1983).
"S-labelled RNA molecules for in situ hybridisation were
prepared according to Senior et al. (1988) by in vitro tran-
scription using the bacteriophage T3 and T7 RNA polymer-
ases and the transcription vector Bluescript SK (Stratagene)
containing an insert of coding sequence of EF-la (829bp
RsaI digest fragment). The quality of transcript was assessed
by electrophoresis through 3.5% polyacrylamide gels con-
taining 20% formamide. Probes were hydrolysed to an
average length of 150-300 nucleotides, using the conditions
and formula of Cox et al. (1984).
Screening libraries
Colony hybridisation was by the method of Grunstein and
Hogness (1975). In addition to the recombinant clones, each
filter contained two colonies of E. coli JM83 carrying the
vector-pUC9 as controls for background hybridisation. The
entire cDNA library of over 21,000 recombinant clones was
screened. The filters were hybridised to a cDNA probe deriv-
ed from a carcinoma, stripped and re-hybridised to a cDNA
probe derived from a fibroadenoma. Duplicate filters were
not used, because the results of colony hybridisation are
dependent upon such factors as the growth rate of individual
clones, the resulting colony size, and the copy number of the
particular plasmid. Comparison of the autoradiographs iden-
tified the colonies which hybridised more strongly to one
probe than the other. One thousand and eighty-seven colon-
ies, containing cDNAs derived from mRNAs of differing
abundance in the specific benign and malignant breast tis-
sues, were selected for a further round of screening with the
same two probes, which reduced the number of differentially
hybridising clones to 325. Further rounds of pairwise (fibro-
adenoma/carcinoma) hybridisations were carried out until a
total of ten comparisons had been made, and 16 clones
remained which showed consistent differential hybridisation.
DNA sequence analysis
The cDNA inserts from clones identified by differential hy-
bridisation were sequenced according to the dideoxy method
of Sanger et al. (1977), using single-stranded template DNA
from the M13 series of bacteriophage vectors. Reaction pro-
ducts were separated on 0.4 mm polyacrylamide gels (Sanger
& Coulson, 1978). Alternatively, double-stranded template
DNA prepared by the method of Kraft et al. (1988) was
sequenced using modified T7 DNA polymerase (SequenaseTm,
United States Biochemical Corporation, Cleveland, USA).
Northern blot analysis
Northern analysis of total RNA was performed as previously
described in Sharp et al. (1990). Washing stringency was
0.2 x SSC at 65°C unless otherwise stated.
RNA slot blots
RNA samples were diluted into a final volume of 100jlI in
DEPC-treated water with a minimal amount ofbromophenol
blue solution (added to follow the progress of the samples),
heated to 65°C for 10min, and then placed on ice. Samples
were applied to nylon membranes (Amersham) using a
Hybri-Slot manifold (Gibco-BRL) and drawn through the
membrane by the application of a low vacuum (Vacublot
pump from LKB, set on 15 cm.H20). Each slot was flushed
with 100Al of 1 x SSC. The filters were then air dried and
the RNA cross-linked to the membrane by ultraviolet irrad-
iation as recommended by the manufacturers. The total
amount of RNA loaded onto each slot was quantified by
hybridising the filters with a probe derived from oligo(dT)-
primed cDNA from a breast cell line MDA-MB-468 total
RNA.
The in situ hybridisation of cRNA probes to sections of
formalin-fixed, paraffin-embedded blocks of resected tumour
tissue was by the method of Walker et al. (1989). Following
dewaxing and rehydration, the sections were digested for
30 min at 37°C with proteinase K at concentrations of 10 fg ml1', 20fLgml-' and 40tigmlhl in order to optimise the
signal/background ratio. Hybridisation and washing was car-
ried out according to Senior et al. (1988). Slides were probed
with 5S radio-labelled RNA (antisense) complementary to the
mRNA or with 35S radio-labelled RNA (sense) homologous to
the mRNA as a negative control. After hybridisation and
washing, the slides were dipped in liquid photographic emul-
sion, left to dry at room temperature over night, and then
autoradiographed for 4-6 weeks in a dry atmosphere at 4C.
After developing and fixing all sections were stained with
haematoxylin and eosin, dehydrated, cleared and coverslips
applied.
Results
Screening ofthe cDNA library
A cDNA library of over 21,000 different clones representing
poly(A)+RNA from a single human breast carcinoma was
constructed and differentially screened using a total cDNA
probe from poly(A)+RNA from the same carcinoma, follow-
ed by rehybridisation with a similar probe derived from a
fibroadenoma RNA. The 1,087 colonies showing differential
hybridisation to the two probes were re-screened with the
same two probes, and were thus reduced to 325. These clones
then underwent further rounds of screening with different
pairs of carcinoma/fibroadenoma-derived probes in order to
find clones that were differentially expressed in a consistent
manner in the two tissue types: consistent was taken arbi-
trarily to mean no more than two contrary results in a total
of ten comparisons. Two clones, C328-5 and C328-8, were
among the 16 clones which showed consistent differential
hybridisation throughout the screening programme. Both
C328-5 and C328-8 showed higher levels of expression in
fibroadenomas than in carcinomas.BREAST TUMOUR DIFFERENTIAL GENE EXPRESSION 67
Characterisation ofC328-5 and C328-8 cDNA sequences
Clone C328-5 contains a 956bp insert which computer-aided
homology searches of the EMBL sequence data base (release
No. 24) identified as a partial cDNA sequence encoding the
a-subunit of the human elongation factor 1 (EF-la) (Brands
et al., 1986). The insert in C328-5 represents sequences start-
ing at position 828 (nucleotide numbering according to
Brands et al., 1986) through to the polyA tail. The coding
sequences determined within clone C328-5 show complete
agreement with the published sequences (Brands et al., 1986;
Ann et al., 1988; Uetsuki et al., 1989). The 3' non-translated
sequences that overlap with the published sequence ofAnn et
al. (1988) contain three single nucleotide differences, but the
extra 97bp distal to these agree with the published genomic
sequences of Uetsuki et al. (1989).
Clone C328-8 contains a 443bp insert which was identified
by computer search as encoding the longer of two identified
sequences for human monoubiquitin carboxyl extension pro-
teins (HUBCEPs), i.e. it encodes the 80 amino acid carboxyl
extension protein (CEP80, Lund et al., 1985). The CEP80
protein has been identified as the human homologue of the
rat basic ribosomal protein S27a (Redman & Rechsteiner,
1989). Clone C328-8 contains sequences from position 95
(Figure lb) (position 45 of the published partial sequence
(Lund et al., 1985)) through to the polyA tail and varies at
only one position (188) in the coding region by a silent
G-*A, but has other differences in the 3' non-translated
sequences (Figure lb).
a
HUBCEP80 cDNA
C328-8
F455-U7
F455-U13
b
1 A 60
CTTTTCGATCCGCCATCTGCGGTGGAGCCGCAACCAAAATGCAGATTTTCGTGAAAACCC
M Q I F V K T L
61
TTACGGGGAAGACCATCACCCTCGAGGTTGAACCCTCGGATACGATAGAAAATGTAAAGG
T G K T I T L E V E P S D T I E N V K A
121
CCAAGATCCAGGATAAGGAAGGAATTCCTCCTGATCAGCAGAGACTGATCTTTGCTGGCA
K I Q D K E G I P P D Q Q R L I F A G K
181 G
AGCAGCTAGAAGATGGACGTACTTTGTCTGACTACAATATTCAAAAGGAGTCTACTCTTC
Q L E D G R T L S D Y N I Q K E S T L H
241 * I.
ATCTTGTGTTGAGACTTCGTGGTGGTGCTAAGAAAAGGAAGAAGAAGTCTTACACCACTC
L V L R L R G G |A K K R K K K S Y T T P
301 . . 360
CCAAGAAGAATAAGCACAAGAGAAAGAAGGTTAAGCTGGCTGTCCTGAAATATTATAAGG
K K N K H K R K K V K L A V L K Y Y K V
361 . . 420
TGGATGAGAATGGCAAAATTAGTCGCCTTCGTCGAGAGTGCCCTTCTGATGAATGTGGTG.
D E N G K I S R L R R E C P S D E C G A
421 * * * . 480
CTGGGGTGTTTATGGCAAGTCACTTTGACAGACATTATTGTGGCAAATGTTGTCTGACTT
G V F M A S H F D R H Y C G K C C L T Y
481 . TA ---- 540
ACTGTTTCAACAAACCAGAAGACAAGTAACTGTATGAGTTAATAAAAGACAT-GAACTAAC (A),,
C F N K P E D K -
Figure 1 cDNA sequence of HUBCEP80. a, cDNA sequences
isolated from C328 (carcinoma) and F455 (fibroadenoma) cDNA
libraries compared with the complete coding sequences of
HUBCEP80. Open box: 5' and 3' non-translated sequences;
hatched box: ubiquitin encoding sequences; solid box: CEP80
encoding sequences. b, Combined cDNA sequence is shown with
deviations in the published sequence (Lund et al., 1985) shown
above and amino acid sequence shown below. Boxed amino acids
indicate the CEP80 protein sequence. Arrow indicates a DdeI
restriction site. The sequence 3' of this from C328-8 were used as
the CEP80-specific probe.
Since neither C328-8 nor the published sequence corre-
sponds to a full length coding sequence, a breast fibro-
adenoma cDNA library (Sharp et al., manuscript submitted)
was screened to isolate full length or overlapping clones
which contain the complete sequence. Two cDNAs were
isolated which hybridised to both ubiquitin and CEP80 DNA
sequences from C328-8. The three overlapping clones to-
gether contain the complete coding sequences of HUBCEP80
(Figure la). These two latter clones are in agreement with the
published sequences at position 188 but differ in the coding
region by a silent A-*G at position 53 (Figure lb).
Expression ofEF-la
Northern analysis using C328-5 insert DNA as a probe
showed that the EF-la cDNA hybridised to a single RNA
species of 1700nt (data not shown), in agreement with pub-
lished data (Uetsuki et al., 1989). In order to confirm that
EF-la is expressed at higher levels in fibroadenomas than in
carcinomas the same probe was hybridised to slot blots
containing total RNA from 16 fibroadenomas and 16 car-
cinomas. The slots were controlled for loading by hybridisa-
tion to a probe for total mRNA from cell line MDA-MB-
468. An empirically-derived transformation of YD = Y07691
(where YD = value measured by laser scanning densitometry)
converted the lag and linear phases of a calibration graph,
from a direct plot of RNA loaded in jig against YD, into a
straight line through the origin. A similar transformation
(YD=Y074"0) gave a straight line through the origin for the
EF-lI probe hybridised to the control serial dilutions of cell
line RNA. Hence, corrected values for EF-la expression in
the tumours could be calculated by a direct ratio (Swillens et
al., 1989). A histogram of these results is shown in Figure 2.
The mRNA expression of EF-lI is significantly greater in the
fibroadenomas than in the carcinomas (P<0.01, Mann-
Whitney U test; Ho: Al = 112; Ha: III # 112). The carcinomas
were a non-homogeneous group, which varied histologically
from well to poorly differentiated, from <2cm in size to
> 5 cm with skin tethering, and including infiltrating ductal,
infiltrating lobular, mucinous and atypical medullary
tumours (Table I). Likewise, the fibroadenomas were non-
homogenous with respect to the ratio of peri- to intra-
canilicular tissue within the tumour. Hence the underlying
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Figure 2 Relative levels of expression of EF-lDx in breast car-
cinomas and fibroadenomas, assayed by RNA slot blot analysis.
Breast tumour RNA was prepared and hybridised as described in
Materials and methods, and the filters probed with the EF-la
cDNA (C328-5). Laser scanning densitometry data are displayed
as a ratio of the signal obtained with the cDNA to the signal
obtained with the reverse transcribed total cDNA probe. These
data have been adjusted for the response curve of the autoradio-
graphic film, as described in methods. The expression levels in
carcinomas and fibroadenomas are significantly different ((P<
0.01) Mann-Whitney U test; Ho: 11 =l 2; Ha: tsI +4 f2) F: fibro-
adenoma (solid bars); C: carcinoma (open bars).68 S.M. ADAMS et al.
Table I Clinical parameters of carcinomas
Sample no. Class Grade Stage
CIO T I 1
C298 ID II 3
C300 ID III NK
C301 ID III 2
C307 ID II 2
C312 ID III 3
C317 ID III 3
C328 ID III I
C336 ID III 2
C378 M II 3
C410 ID III 2
C446 ID III 3
C670 AM III NK
C712 ID III NK
C714 ID III 1
C719 ID I 1
C718 IL II 1
AM: atypical medullary; ID: infiltrating ductal; IL: infiltrating
lobular; M: mucinous; T: tubular; NK: not known.
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distribution of gene expression in these tumour types is unk-
nown and cannot be assumed to be normal. Therefore the
non-parametric Mann-Whitney U test was used.
Representative in situ hybridisation of riboprobes to sec-
tions of fixed tissue from carcinomas and fibroadenomas is
shown in Figure 3. In both carcinoma and fibroadenoma
samples the antisense riboprobe hybridised at a low level to
most stromal cells, with higher levels of labelling over normal
breast epithelia and blood vessel endothelium. Labelling of
the ductular components of the fibroadenomas was relatively
even (Figures 3a and 3b), and involved both epithelium and
myoepithelium. Stromal cells generally gave a lower level of
labelling although this was variable (Figure 3b). The car-
cinomas showed a greater variation in the labelling of the
tumour cells. Areas within ductal carcinoma in situ had
greater labelling of cells than adjacent invasive tumour
(Figure 3c). In both tissue types the sense riboprobe showed
only non-specific hybridisation at background levels (Figure
3d).
b
d
Figure 3 a, Low power view of a fibroadenoma with a predominantly pericanilicular pattern showing labelling of all ductal
components. b, Higher power view of an intracanilicular-type duct, with labelling of epithelium and myoepithelium. The stromal
cells have a variable labelling pattern. c, Carcinoma 312 with an area of ductal carcinoma in situ showing prominent labelling of
cells. Adjacent to it there are small groups of infiltrating tumour cells (arrowed) which show a lower level of labelling. d,
Fibroadenoma probed with sense riboprobe, there being no specific hybridisation.BREAST TUMOUR DIFFERENTIAL GENE EXPRESSION 69
Expression ofHUBCEP80
Northern analysis of poly(A)+RNA from three cell lines
(MDA MB 231, MCF 7 & HS578T) showed that a ubiquitin-
sequence specific probe detected mRNA species at 2,300,
1,100 and 660nt, whilst the corresponding CEP80 sequence-
specific probe detected only the 660nt species (data not
shown). These results agree with those obtained by Wiborg et
al. (1985). The 660nt species was by far the most abundant of
the three species in these cell lines. Northern analysis of total
RNA from seven fibroadenomas and seven carcinomas show-
ed that CEP80 sequences are expressed significantly more in
fibroadenomas than in carcinomas (Mann-Whitney U test
(P<0.02) Ho: t1- = i2; Ha: 1 + 2) (Figure 4).
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Discussion
Differential screening of a carcinoma cDNA library with
probes derived from ten different, arbitrary fibroadenoma/
carcinoma pairings identified 16 clones that were consistently
expressed to different levels in one tumour type compared
with the other. Of these, two were found to encode sequences
for the translation-associated proteins EF-la and CEP80.
Both these sequences had higher levels of expression in
benign (fibroadenoma) than in malignant (carcinoma)
tumours, as seen in the RNA slot blot analysis for EF-la
(Figure 2) and Northern analysis for CEP80 (Figure 4). In
addition, we have previously found enhanced expression of
another translation-associated protein, P2, in benign compared
with malignant tumours (Sharp et al., 1990). In situ hybri-
disation of EF-lx riboprobes to carcinoma and fibroaden-
oma tissues showed that the higher levels of expression
resided mainly in the tumour cells or normal glandular struc-
tures rather than in the stromal cells, although the fibro-
adenomas did contain varying numbers of stromal cells with
higher levels of expression. The opposite was the case for
stromelysin-3, a new member of the family ofmetalloprotein-
ases which degrade the extracellular matrix, where the gene
was specifically expressed in the stromal cells surrounding
invasive breast carcinomas (Basset et al., 1990).
Since quantification of in situ hybridisation is difficult it
was not possible to determine the relative levels ofexpression
of EF-la mRNAs in carcinomas and fibroadenomas by this
method. However, a number of interesting features could be
observed. The frankly invasive carcinoma cells ofC312 show-
ed lower expression than cells of adjacent ductal carcinoma
in situ which is of interest since the intraductal carcinoma
represents an earlier stage of the disease.
There is one report of a novel sequence, pGM21, isolated
by differential screening of a subtractive cDNA library con-
structed from a poorly metastatic rat mammary adenocar-
cinoma cell line (DMBA8) and a highly metastatic variant
line (DMBA8 ascites) and found to be associated with high
metastatic potential (Phillips et al., 1990). This gene was said
to contain a 45 nucleotide segment homologous to human
EF-la cDNA (Brands et al., 1986), however, this is incorrect
and there is no significant homology of pGM21 to any
published sequence. A retraction to this effect will be pub-
lished (I.A. Ramshaw, personal communication).
The process of peptide elongation is fundamental to the
function of all living cells and is highly conserved between
prokaryotes and eukaryotes. Hence, regulation of the compo-
nent parts is critical to normal development of the cell. Of
the two translation-associated proteins considered here, EF-
lot is responsible for targetting the incoming aminoacyl-
tRNA to the ribosome which leads to incorporation of the
amino acid and elongation of the nascent peptide. Besides its
essential role in peptide elongation, EF-la may also play a
key part in the regulation of a number of important cellular
functions. For example, EF-la is found in association with
membranes and tubulin (Janssen & Moller, 1988), endoplas-
mic reticulum (Hayashi et al., 1989), the mitotic apparatus
(Ohta et al., 1990) and the cytoskeletal apparatus (Yang et
al., 1990). The amount of EF-la within the cell is controlled
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Figure 4 Relative levels of expression of HUBCEP80 gene in
breast carcinomas and fibroadenomas, as shown by Northern
blotting. Breast tumour RNA was electrophoresed and blotted
according to Materials and methods, and the filters probed with
a, CEP80 (see Figure 1), stripped and reprobed with b, radio-
labelled cDNA synthesised by reverse transcription of 4.65 Lg
oligo(dT) primed total RNA from cell lines MDA MB 231,
HS578T, HeLa, fibroadenomas F524, F672 and carcinoma C690
in a ratio of 15: 8: 1: 2.5: 10: 10 as a control for mRNA loading.
Sizes of transcripts are in nucleotides. Filters were washed to a
stringency of 0.5 x SSC at 65°C. Laser scanning densitometry
data, corrected for mRNA loading, are displayed c, as a percen-
tage of the highest signal obtained from any tumour - i.e.
fibroadenoma F524. The expression levels in carcinomas and
fibroadenomas are significantly different (P<0.02, Mann-
Whitney U test; Ho: IAI = 112; Ha: J + 'A2) F: fibroadenoma (solid
bars); C: carcinoma (open bars).
at the transcriptional level as well as translationally and
post-translationally.
There is evidence that EF-la also plays an important role
in ageing. During successive passages of mortal fibroblasts
there is a decline in the amount of activity of EF-la as the
cells reach the limit of their in vitro lifespan (Cavallius et al.,
1986). Shepherd et al. (1989) reported that Drosophila mela-
nogaster have increased longevity when over-expressing an
extra copy of EF-la introduced by P-element plasmid trans-
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formation. Our findings of higher levels of EF-la gene ex-
pression in fibroadenomas compared with carcinomas could
be related to a greater cell longevity in fibroadenomas, which
is observed as an overall greater growth rate in many fibro-
adenomas (Meyer, 1977).
The second ribosomal protein isolated in this study was
the linear ubiquitin adduct HUBCEP80 co-translated as a
single polypeptide from a transcript of a natural fusion gene,
in which the codon for the terminal glycine of ubiquitin is
followed immediately by the initial alanine codon for the 80
amino acid extension protein (CEP80). Northern analysis
(Figure 4) showed that the CEP80 sequences were different-
ially expressed in a similar fashion to EF-la in the two
tumour types (i.e. C328-8 showed higher expression in fibro-
adenomas than in carcinomas).
CEP80 has been identified as the human homologue of the
rat basic ribosomal protein S27a (Redman & Rechsteiner,
1989). The S27a protein is one of about 30 ribosomal pro-
teins found in the small (40S) subunit of eukaryotic
ribosomes. The homologue in Saccharomyces cerevisiae
(CEP76, Ozkaynak et al., 1987) is involved in pre-rRNA
processing at the step where 20S rRNA is cleaved to 18S
rRNA. Mutants with deletions in the UBB3 gene encoding
CEP76 in S. cerevisiae are deficient in 18S rRNA because the
20S rRNA is degraded instead of being processed (Finley et
al., 1989). Induced expression of human HUBCEP80 causes
growth inhibition in S. cerevisiae (Monia et al., 1989). The
CEP80 sequences and not the ubiquitin sequences are respon-
sible for this inhibition. Equally, under-expression of CEPs
affects growth, as seen in the slower growth rates of deletion
mutants of UBIJ, UB12 and UB13 of S. cerevisiae (Finley et
al., 1989). All these observations suggest that the regulation
of CEP production in cells must be critical for normal
growth (Monia et al., 1989). The differing levels of CEP80
expression in fibroadenomas and carcinomas possibly reflect
aberrant regulation of CEP80 sequences.
In the present study we have identified two translation-
associated proteins as being involved in differential mRNA
expression in benign and malignant tumours. We have pre-
viously described a similar expression profile for a sequence
encoding the large ribosomal subunit acidic phosphoprotein
P2 and we discussed that this was unlikely to be due to the
rates of proliferation of the tumour types compared (Sharp et
al., 1990). We have, therefore, presented evidence that a
number of key components in the translation machinery
show differential expression in malignant breast disease.
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